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Substrate stiffnessCalponin is an actin ﬁlament-associated protein and its h2 isoform inhibits cell motility. Here we
report signiﬁcant expression of h2-calponin in prostate epithelial cells, which is diminished in can-
cerous cells. Comparison between a prostate cancer cell line PC3 and its metastatic derivative PC3-M
showed lower levels of h2-calponin in PC3-M, corresponding to faster rates of cell proliferation and
migration. Substrate adhesion of PC3 and PC3-M cells was positively correlated to the level of h2-cal-
ponin and the adhesion of PC3-M exhibited a higher dependence on substrate stiffness. Such effects
of h2-calponin on cell proliferation, migration and substrate adhesion were also seen in normal ver-
sus cancerous primary prostate cells. Further supporting the role of h2-calponin in inhibiting cell
motility, ﬁbroblasts isolated from h2-calponin knockout mice proliferated and migrated faster than
that of wild type ﬁbroblasts. Transfective over-expression of h2-calponin in PC3-M cells effectively
inhibited cell proliferation and migration. The results suggest that the diminished expression of h2-
calponin in prostate cancer cells increases cell motility, decreases substrate adhesion, and promotes
adhesion on high stiffness substrates.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Prostate cancer is the most common malignant tumor in men in
Western countries [1] and has a high frequency of bone metastasis
[2]. The molecular and cellular mechanisms leading to the develop-
ment of bonemetastasis of prostate cancer are not fully understood.
Cancer metastasis is a process involving tumor cell proliferation,
detachment, intravasation, adhesion to vascular endothelial cells,
extravasation, invasion, and growth in distant organs [3]. Cell
motility plays a fundamental role in every step of this process,
and the function of actin cytoskeleton is vital for cell division [4]
and migration [5]. Alterations of actin [6,7] and actin-associated
proteins, including h1-calponin [8], have been implicated in cancer
metastasis.Calponin is an actin ﬁlament-associated regulatory protein orig-
inally found in smooth muscle cells [9]. Three homologous iso-
forms of calponin, h1, h2 and h3 (acidic), have been identiﬁed in
vertebrate species [10]. H1-calponin [11] is speciﬁcally expressed
in differentiated smooth muscle cells and has been extensively
studied for its role in the regulation of smooth muscle contractility
[12]. Acidic calponin was ﬁrst found in the brain with a possible
function in neuronal regeneration and growth [13,14]. Expression
of h2-calponin has been found in both smooth muscle [11] and
non-muscle cells including epidermal keratinocytes [15,16], lung
alveolar cells [17], endothelial cells [18,19], ﬁbroblasts [17,20]
and myeloid blood cells [21]. The function of h2-calponin includes
stabilizing actin cytoskeleton [16] and inhibiting cytokinesis [22].
Biochemical properties of calponin were most extensively studied
in chicken smooth muscle h1-calponin [10]. The conserved struc-
tures of h1, h2 and acidic calponins suggest conserved functional
mechanisms [23].
H1-calponin was found in normal prostate tissue with a loss in
prostate cancer [24]. A previous study reported that the level of h1-
calponin was decreased in smooth muscle-derived cancerous tis-
sues with a correlation to metastasis phenotypes and prognosis
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to be determined, the decreased level of h1-calponon in prostate
cancer may indicate a destruction of smooth muscle-like stroma
cells [25]. On the other hand, epithelial cells are major component
in prostate gland, from which prostate carcinomas are originated.
Consistent with the expression of h2-calponin in other epithelial
cell types [16,17], h2-calponin is recently reported in prostate can-
cer cells and loss of h2-calponin induced cellular protrusions and
increased cell migration [26].
In the present study, we examined the expression of h2-calpo-
nin in prostate cancer tissues and cells. Signiﬁcant levels of h2-cal-
ponin were detected in the epithelia of normal prostate, which
were diminished in cancerous prostate epithelial cells. Comparison
between a prostate cancer cell line PC3 and its metastatic deriva-
tive PC3-M [27] showed a signiﬁcantly lower level of h2-calponin
in PC3-M. Correspondingly, PC3-M cells proliferated more rapidly
and migrated faster. Transfective overexpression of h2-calponin
in PC3-M cells effectively inhibited cell proliferation and migration.
Supporting the role of h2-calponin in inhibiting cell motility, ﬁbro-
blasts isolated from h2-calponin knockout mice proliferated and
migrated faster than that of wild type ﬁbroblasts. The adhesion
of PC3 and PC3-M cells to culture substrate exhibited positive cor-
relation with the level of h2-calponin, in which the adhesion of
PC3-M cells was more dependent on substrate stiffness than that
of PC3. These results suggest that the loss of h2-calponin in pros-
tate cancer cells may contribute to the potency of metastasis, espe-
cially metastasis to the bone that is a high stiffness substrate.
2. Results
2.1. Presence of h2-calponin in prostate epithelial cells and its
decreases in prostate cancer
A previous proteomic study reported a loss of h1-calponin in
prostate cancer in comparison with non-cancerous prostate tissues
[24]. Consistently, we also detected h1-calponin in non-cancerous
prostate tissue and decreases in cancer tissue with immunohisto-
chemistry and Western blotting using anti-h1-calponin monoclo-
nal antibody (mAb) CP1 (Fig. 1A).
RAH2 and mAb 1D2 Western blots on total protein extract fur-
ther detected h2-calponin in non-cancerous human prostate tis-
sue. The prostate h2-calponin was also diminished in cancerFig. 1. H2-calponin in prostate epithelia and its diminishment in cancerous
prostate tissue. (A) Total protein extracts from hyperplasia or cancerous human
prostate biopsies were analyzed with Western blots using anti-h1-calponin mAb
CP1 and anti-h2-calponin polyclonal antibody RAH2 and mAb 1D2. The blots
detected signiﬁcant amounts of h1- and h2-calponins in the non-cancerous prostate
tissue. Relative to the level of actin, h1-calponin was signiﬁcantly decreased and h2-
calponin became undetectable in the cancerous prostate tissues. (B) Thin parafﬁn
sections of hyperplasia or cancerous human prostate tissues were examined with
H&E staining and immunohistochemistry using anti-h2-calponin mAb 1D2 and
SP2/0 myeloma cultural supernatant control. The results showed signiﬁcant
amount of h2-calponin in non-cancerous prostate gland epithelial cells but not in
the cancerous tissue.(Fig. 1A). Immunohistochemistry localized h2-calponin in the epi-
thelial cells of human prostate gland, which became undetectable
in prostate cancer tissue (Fig. 1B).
The expression of h2-calponin but not h1-calponin in prostate
epithelial cells was conﬁrmed by Western blots in human prostate
cancer cell line PC3 and its metastatic derivative PC3-M, together
with two pairs of non-cancerous versus cancerous primary pros-
tate epithelial cell lines 1542NPTX/1542CP3TX and 1532NPTX/
1532CPTX (Fig. 2A).
Normalized to the level of actin, densitometry quantiﬁcation of
the Western blots found that the level of h2-calponin in PC3-M
cells was 34% lower than that in PC3 (Fig. 2B), implicating a cor-
relation to the metastatic phenotype. Similarly, the cancerous
1542CP3TX cells had a signiﬁcantly lower level of h2-calponin than
that in the non-cancerous 1542NPTX cells (Fig. 2C). On the other
hand, the cell pair 1532CPTX and 1532NPTX showed no signiﬁcant
difference in the level of h2-calponin (Fig. 2D). The different levels
of h2-calponin in these primary prostate cancer cell lines indicate
variations in biological characteristics among individual cancer
patients, of which the 1532CPTX/1532NPTX cells expressing simi-
lar levels of h2-calponin provide a useful control pair for our study
of the role of h2-calponin in prostate cancer cell motility.
Confocal microscopic images of PC3 and PC3-M cells showed
that h2-calponin co-localized with F-actin (Fig. 3A), consistent
with the role of h2-calponin in actin-mediated cellular functions
such as migration and proliferation [21,22]. Fluorescence intensity
of the confocal images conﬁrmed that PC3-M cells contained a
lower level of h2-calponin than that in PC3 (Fig. 3B). There was
no qualitative difference in the cellular distribution of h2-calponin
in PC3 and PC3-M cells.Fig. 2. Expression of h2-calponin in prostate epithelial cells. (A) RAH2, CP1 and
CP21 Western blots of total protein extracts from prostate epithelial and cancer cell
lines (PC3 versus PC3-M, 1542NPTX versus 1542CP3TX and 1532NPTX versus
1532CPTX) detected signiﬁcant expression of h2-calponin but not h1-calponin. (B)
Normalized to the level of actin, densitometry quantiﬁcation of RAH2 blots showed
that the metastatic PC3-M cells express signiﬁcantly less h2-calponin than that in
PC3 cells (⁄P < 0.001). (C) The cancerous 1542CP3TX cells also expressed less h2-
calponin than that in 1542NPTX cells derived from the non-cancerous portion of the
same prostate (⁄P < 0.001). (D) The 1532NPTX and 1532CPTX cells express similar
levels of h2-calponin, providing a pair of control cells.
Fig. 3. Localization of h2-calponin in PC3 and PC3-M cells. (A) Monolayer cultures of PC3 and PC3-M cells were stained with anti-h2-calponin mAb 1D2 and phalloidin. The
result showed that h2-calponin co-localized with F-actin in these cells. (B) Normalized to cell area, ﬂuorescence intensity analysis of confocal microscopic images showed that
PC3-M contained less h2-calponin than that in PC3 cells (⁄P < 0.005).
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proliferation
Comparison between the growth curves of PC3 and PC3-M cells
showed that PC3-M proliferated signiﬁcantly faster than that of
PC3 (Fig. 4A), demonstrating a correlation to the lower level of
h2-calponin in PC3-M cells. This inverted correlation between
the level of h2-calponin and the rate of cell proliferation was con-
ﬁrmed by the faster proliferation rate of 1542CP3TX versus that of
1542NPTX cells expressing low versus high levels of h2-calponin,
in contrast to the lack of difference between 1532CPTX and
1532NPTX cells that express similar levels of h2-calponin (Fig. 4B).
To demonstrate the causal effect of decreased h2-calponin on
the increased proliferation of prostate cancer cells, boosting the
level of h2-calponin in PC3-M cells by stable transfective overex-
pression (Table 1) effectively suppressed the rate of proliferation
(Fig. 4D).
2.3. The loss of h2-calponin increased prostate cancer cell migration
In vitro scratch wound healing assay showed that PC3-M cells
healed the wound faster than that of PC3 (Fig. 5A), consistent with
the role of h2-calponin in inhibiting cell migration [21]. Therefore,
the decreased level of h2-claponin in PC3-M cells may contribute
to its high motility and metastatic phenotype in comparison to
its parental PC3 cells [27]. As in the proliferation assay described
above, the h2-calponin-dependent inhibition of prostate cancer
cell migration was further demonstrated using primary prostate
cell lines 1542CP3TX (low h2-calponin) versus 1542NPTX (high
h2-calponin) with no difference between the 1532NPTX/1532CPTX
control pair that express similar levels of h2-calponin (Fig. 5B).
Raising the level of h2-calponin in PC3-M cells by transfective
over-expression (Fig. 6A) effectively inhibited the rate of cell
migration in wound healing experiments as shown by therepresentative cell lines with high and low levels of stable transfec-
tive overexpression (Fig. 6B; Table 1). The results support a causal
role of decreased h2-calponin in the high motility phenotype of
metastatic prostate cancer cells.
2.4. Substrate stiffness determines the expression of h2-calponin in
prostate cancer cells
We previously reported that the expression of h2-calponin is
regulated by the stiffness of culture substrate [16]. In comparison
to the effect of rigid or high stiffness substrates, soft substrates that
produce lower traction force in the cytoskeleton [36] decreased h2-
calponin expression in epidermal keratinocytes, ﬁbroblasts [16]
and lung alveolar cells [17]. The present study demonstrated that
this is also true for PC3 and PC3-M prostate cancer cells. The results
in Fig. 7 showed that PC3 and PC3-M cells cultured on low stiffness
soft polyacrylamide gel (elastic modulus = 1 kPa) expressed signif-
icantly less h2-calponin than that in cells cultured on high stiffness
hard gel (elastic modulus = 8 kPa). The high level expression of h2-
calponin in cells grown on hard gel was similar to that in cells
grown on plastic dish, indicating that the physical stiffness, other
than the chemical property, of the cultural substrates determined
the level of h2-calponin in prostate cancer cells. Together with
the previous studies on other cell types, the results demonstrated
a conserved regulation of h2-calponin gene expression by cytoskel-
eton tension in response to the stiffness of culture substrate.
2.5. The loss of h2-calponin decreased substrate adhesion of prostate
cancer cells
To demonstrate the effect of h2-calponin on cell adhesion, more
PC3 cells than PC3-M cells were attached to uncoated plastic plates
up to 8 h after plating (Fig. 8A). This difference was further shown
in adhesion experiments using collagen-coated plastic plates.
Fig. 4. Loss of h2-calponin in prostate cancer cells increases the rate of cell proliferation. (A) The growth curves demonstrated that PC3-M cells proliferated signiﬁcantly faster
than that of PC3 cells (⁄P < 0.001, n = 4 experiments). (B) 1542CP3TX cells also proliferated faster than that of 1542NPTX (⁄P < 0.001, n = 3 experiments). Different from the two
cell pairs expressing different levels of h2-calponin, there was no difference in the proliferation rates of 1532NPTX and 1532CPTX cells that express similar levels of h2-
calponin (Fig. 2D). (C) The SDS–PAGE gel and RAH2 Western blot demonstrated the deletion of h2-calponin in ﬁbroblasts isolated from h2-calponin gene knockout mice. The
growth curves showed signiﬁcantly higher proliferation rate of the h2-calponin-null cells as compared with the wild type control (⁄P < 0.001, n = 4 experiments). (D) Western
blots and densitometry quantiﬁcation showed that transfective overexpression of mouse h2-calponin increased the total h2-calponin in PC3-M cells (⁄P < 0.001, n = 3). The
growth curves showed that the boost up of total h2-calponin to levels similar to that in PC3 cells (Table 1) effectively decreased the proliferation rate of PC3-M cells
(⁄P < 0.001, n = 4 experiments). Transfected G418-resistant PC3-M cells that do not overexpress mouse h2-calponin were used as control.
Table 1
Relative level of h2-calponin expression in PC3, PC3-M and transfected PC3-M cells.
Cell line Level of h2-calponin (% of PC3)
PC3 100.00 ± 6.02
PC3-M 66.07 ± 5.91⁄
Transfected PC3-M (low overexpression)a 99.93 ± 6.09,§
Transfected PC3-M (high overexpression)b 190.46 ± 38.81–,#,
The relative levels of total h2-calponin expressed in PC3, PC3-M and mouse h2-
calponin cDNA stable transfected PC3-M cells were quantiﬁed from Western blots
by normalization to the level of actin shown in parallel SDS-gel. Densitometry
comparisons showed that the lower level of h2-calponin in PC3-M versus PC3 cells
(⁄P < 0.001) was effectively boosted up by transfective overexpression (Low over-
expression versus PC3-M: P < 0.001; –High overexpression versus PC3-M: P < 0.001;
#High overexpression versus PC3: P < 0.001; High versus low overexpression:
P < 0.001. The low overexpression boosted the h2-calponin level in PC3-M cells up
to levels similar to that in PC3 cells (§P = 0.493). The cell proliferation and round up
experiments were carried out using transfective low overexpression PC3-M cells for
comparison with non-transfected PC3-M and PC3 cells. a, 4 stable cell lines; b, 6
stable cell lines. n = 3 experiments.
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PC3-M cells (Fig. 8B).
It was interesting to observe that the proportion of adhered
cells became similar between PC3 versus PC3-M 24 h after seeding
to uncoated plates and 1 h after seeding to collagen-coated plates
(Fig. 8A and B). This preserved maximum adhesion suggests that
h2-calponin functions in accelerating the speed, other than
the capacity, of cell adhesion. The similar trends of adhesion of
the cells to uncoated and collagen-coated plates suggested that
the effect of h2-calponin on cell adhesion is independent of colla-
gen receptors, in which the slower adhesion to uncoated plates
reﬂects the effect of cell-secreted collagen on facilitating overall
adhesion.
Supporting the role of h2-calponin in enhancing cell adhesion,
the spreading area of PC3-M cells on plastic substrate was signiﬁ-
cantly smaller than that of PC3 cells (Fig. 8C). Also consistent with
the role of h2-calponin in stabilizing actin cytoskeleton [16], the
lower level of h2-calponin in PC3-M cell correlated to faster
Fig. 5. Decrease or loss of h2-calponin facilitates cell migration. (A) In vitro scratch wounding healing experiments showed that PC3-M cells started migration and closed the
wound earlier than that of PC3 (⁄P < 0.001, n = 3 experiments). (B) 1542CP3TX cells also migrated faster and closed the wound earlier than that of 1542NPTX (⁄P < 0.001, n = 3
experiments). In contrast to the two cell pairs expressing different levels of h2-calponin, 1532CPTX and 1532NPTX cells that express similar levels of h2-calponin (Fig. 2A)
migrated at similar speed in the wounding healing experiments. (C) Supporting the role of h2-calponin in inhibiting cell motility, h2-calponin-null mouse ﬁbroblasts (Fig. 4C)
started migration and closed the wound earlier than that of the h2-calponin-posirtive wild type ﬁbroblasts (⁄P < 0.001, n = 4 experiments).
Fig. 6. Boosting up the level of h2-caponin inhibited the migration of prostate cancer cells. When the level of total h2-calponin in PC3-M cells was increased by transfective
expression as shown by the RAH2Western blots and densitometry quantiﬁcation (A) ⁄P < 0.001 versus non-transfected control; #P < 0.001 between the high and low levels of
transfective expression as normalized to the amount of actin (Table 1), the rate of cell migration decreased correspondingly (B) ⁄P < 0.001, n = 3 experiments.
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Fig. 7. Substrate stiffness-dependent expression of h2-calponin in prostate cancer
cells. (A) PC3 and PC3-M cells were cultured for 3 days on thin layers of
polyacrylamide gels of high (8 kPa) or low (1 kPa) stiffness and on plastic dish
control. (B) The level of h2-calponin expressed in the cells was determined with
Western blot using RAH2 antibody. Normalized to the level of actin, densitometry
quantiﬁcation showed lower expression of h2-calponin in both PC3 and PC3-M cells
grown on soft polyacrylamide gel than that in cells cultured on hard gel or plastic
substrates (⁄P < 0.001, n = 4 experiments).
Fig. 8. Positive correlations between the level of h2-calponin and cell adhesion. (A)
The time courses showed that in the ﬁrst 8 h after plating, PC3 cells adhered to
uncoated culture plates more than that of PC3-M cells, whereas the maximum
adhesion capacity as shown at 24 h after plating was unchanged. (B) The effect of
the higher level of h2-calponin in PC3 cells on facilitating adhesion was further
shown in adhesion to collagen coated cultural plates in 30 min after plating
(⁄P < 0.05; ⁄⁄P < 0.001. n = 3 experiments). (C) The cell spreading area in adherent
monolayer cultures was positively correlated to the level of h2-calponin as shown
by the difference between PC3 and PC3-M cells. (D) Correspondingly, the speed of
cell roundup during trypsin digestion of adherent cultures was negatively corre-
lated to the level of h2-calponin, in which the roundup of PC3 cells was slower than
that of PC3-M and transfective overexpression of h2-calponin in PC3-M cells to
boost the level of total h2-calponin to that similar to the level in PC3 cells (Table 1)
reversed the trend (⁄P < 0.001, n = 4 experiments).
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higher level of h2-calponin (Fig. 8D). Transfective overexpression
of h2-calponin in PC3-M cells (Table 1) effectively slowed the
roundup velocity (Fig. 8D).
2.6. Loss of h2-calponin increased the dependence of prostate cancer
cell adhesion on substrate stiffness
We examined PC3 versus PC3-M, 1542NPTX versus 1542CP3TX
prostate cells, and 1532NPTX versus 1532CPTX control prostate
cells for their adhesions to hard and soft gel substrates. The results
in Fig. 9A, C and E showed that all of these cell lines adhered with
lower numbers to low stiffness soft substrate than that to high
stiffness hard substrate. PC3-M (Fig. 9A) and 1542CP3TX (Fig. 9C)
cells adhered less than that of their counterparts expressing higher
levels of h2-calponin. There was no difference between 1532CP3TX
and 1532NP3TX cells that express similar levels of h2-calponin
(Fig. 9E).An interesting observation was that the adhesion of low h2-cal-
ponin cells was more dependent on substrate stiffness. The com-
parisons in Fig. 9B and D demonstrated that high stiffness
substrate had signiﬁcantly greater enhancement for the adhesion
of PC3-M and 1542CP3TX cells than that for their counterparts
expressing higher levels of h2-calponin. Such pattern was not seen
between 1532CP3TX and 1532NP3TX cells that express similar
level of h2-calponin (Fig. 9F). These data suggest that the decreased
level of h2-calponin in prostate cancer cells may increase the pref-
erence of adhesion to high stiffness substrates. This mechanism
may contribute to prostate cancer’s high tendency of metastasis
to the bone that provides a uniquely high stiffness tissue
environment.
3. Discussion
The present study investigated the expression and function of
h2-calponin in prostate cancer cells. The following ﬁndings are of
notable signiﬁcance:
3.1. The expression of h2-calponin in prostate gland epithelial cells and
its diminishment in prostate cancer
The Western blot and immunohistochemistry data in Fig. 1
demonstrated that prostate gland epithelial cells express signiﬁ-
cant amounts of h2-calponin, which were diminished in cancerous
prostate tissues. This ﬁnding was conﬁrmed by the signiﬁcant
amount of h2-calponin in the prostate cancer cell line PC3 and
the decreased expression in its metastatic derivative PC3-M.
Fig. 9. Decreases in h2-calponin increased the dependence of prostate cancer cell
adhesion on substrate stiffness. Demonstrating the positive correlation between
h2-calponin and substrate stiffness dependent cell adhesion, the results of cell
adhesion to polyacrylamide gel substrates showed that PC3-M (A) and 1542CP3TX
(C) adhered less in comparison with that of PC3 and 1542NPTX, respectively. The
data further showed that less cells adhered to soft gel substrate than that to hard
gel (⁄P < 0.001). In contrast, 1532CPTX and 1532NPTX cells that express similar
levels of h2-calponin (Fig. 2D) showed no difference in adhesion to substrates (E).
Panels B and D illustrate the ratio of cells adhered to high versus low stiffness gel
substrates. Comparing with cells expressing high levels of h2-calponin, cells
expressing lower level of h2-calponin had signiﬁcantly higher increases in cell
adhesion to high stiffness substrate versus that to low stiffness substrate
(⁄P < 0.001). 1532CPTX and 1532NPTX cells that express similar levels of h2-
calponin showed no such difference (F). The data were summarized from four
repeated experiments.
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cancer tissues [24] was also conﬁrmed in our study. It is important
to emphasize that h1-calponin is known to express speciﬁcally in
smooth muscle cells [12,37]. Since h1-calponin is not detected in
the gland epithelial cells of prostate tissue (Fig. 1) or epithelial/car-
cinoma-derived cell lines (Fig. 2), the detection of h1-calponin in
normal prostate tissue may reﬂect its presence in stroma smooth
muscle-like cells and its diminishment in prostate cancer may
reﬂect lesions destroying the organ structure.
H2-calponin is expressed in smooth muscles [11] as well as in
various non-muscle cells, including epithelial cells [15–17]. H2-
calponin in prostate epithelial cells with a functional signiﬁcance
in cancer cell proliferation, migration and adhesion is a novel
observation. The decreased h2-calponin in metastatic prostate can-
cer cells is consistent with a report that lower levels of h1-calponin
in leiomyosarcoma were correlated to metastasis and poorer prog-
nosis [8]. It is worth noting that decreased h2-calponin was not
uniformly seen in all prostate cancers examined (Fig. 2), but with
strong correlation to cell motility features. Therefore, decreases
in h2-calponin may be explored as a potential biomarker for the
evaluation of the degree of malignancy of prostate cancer in indi-
vidual patients.3.2. Decreases in h2-calponin increase prostate cancer cell
proliferation and motility
H2-calponin has been shown to affect the structural organiza-
tion [15,38] and stability [16] of actin cytoskeleton. The actin cyto-
skeleton undergoes dynamic remodeling during cell proliferation
and migration, which are key steps in tumor progression and
metastasis. We previously demonstrated that over-expression of
h2-calponin effectively reduced the rate of cell proliferation by
inhibiting cytokinesis [22]. PC3-M cells with increased metastatic
ability [27,39] have decreased level of h2-calponin (Fig. 2) and pro-
liferated and migrated faster than that of the less metastatic PC3
cells (Figs. 4 and 5). The faster proliferation and migration of
PC3-M cells were effectively suppressed by transfective overex-
pression of h2-calpon (Figs. 4 and 6).
To demonstrate that the effect of decreased h2-calponin on the
proliferation and motility of prostate cancer cells is not restricted
to the PC3 versus PC3-M cells, the correlation between decreases
in h2-calponin and increased rates of cell proliferation and migra-
tion was further demonstrated in the non-malignant 1542NPTX
versus malignant/cancerous 1542CP3TX prostate endothelial cells
from the same patient (Figs. 4 and 5). As a control, the 1532NPTX
versus 1532CPTX cell pair that express similar levels of h2-calpo-
nin proliferated and migrated at similar rates (Figs. 4 and 5).
The inhibitory effect of h2-calponin on cell proliferation and
migration was further conﬁrmed by the signiﬁcantly faster prolif-
eration and migration rates of ﬁbroblasts from h2-calponin knock-
out mice in comparison to that of wild type ﬁbroblasts expressing a
high level of h2-calponin (Fig. 4C and Fig. 5C). These data suggest
that decreases in h2-calponin in prostate cancer cells may contrib-
ute to malignant growth and metastasis through facilitating
remodeling of the actin cytoskeleton during cell proliferation and
migration.
3.3. Decreases in h2-calponin alter prostate cancer cell adhesion
Extensive studies have investigated the chemical environment
of bone tissue underlying prostate cancer’s high tendency of bone
metastasis [2]. It has been observed that living cells dynamically
change structure and function through gene regulation and post-
translational protein modiﬁcation in response to mechanical envi-
ronment [40–44]. A potential contribution of the high stiffness
mechanical environment in bone tissue to the metastasis of pros-
tate cancer suggests an interesting new direction of research.
Based on calponin’s established role as a cytoskeleton regulatory
protein [10,12] that is responsive to mechanical tension environ-
ment [16,17,45], our study of normal versus cancerous prostate
epithelial and cancer cells differing in metastatic potency explored
the role of h2-calponin in prostate cancer cell adhesion and the
dependence on substrate stiffness.
Our results demonstrated that decreases in h2-calponin slowed
prostate cancer cell adhesion to both soft and hard substrates
(Fig. 7). Consistent with the role of h2-calponin in stabilizing actin
cytoskeleton [16], we demonstrated that decreases in h2-calponin
slowed cell adhesion, reduced cell spreading area and facilitated
cell roundup during trypsin digestion (Fig. 8). On the other hand,
substrate stiffness is known to up-regulate h2-calponin gene
expression [16,17,45]. The high stiffness substrate environment
in bone tissue would, therefore, result in higher levels of h2-calpo-
nin in adhered cells, which in turn stabilize the cell adhesion to
promote metastatic anchor of arriving cancer cells.
The observation that low in h2-calponin resulted in higher
dependence of prostate cancer cell adhesion on substrate stiffness
(Fig. 9) suggests that diminishment of h2-calponin in prostate can-
cer cells may contribute to the high tendency of metastasis to bone
that provides a unique high stiffness substrate environment. This
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more important for cancer cells that had primarily decreased
expression of h2-calponin to sustain a critical level of h2-calponin
protein and maintain a stable actin cytoskeleton by adhesion on
high stiffness substrates. The h2-calponin-dependent effect of sub-
strate stiffness on prostate cancer cell adhesion suggests a poten-
tially novel therapeutic target to prevent bone metastasis and
merits further investigation.4. Materials and methods
The examination of de-identiﬁed diagnostic human tissue sam-
ples removed during surgery was determined as exempt research
by the institutional Human Investigation Committee. The study
of mouse cells was carried out using protocols approved by the
Institutional Animal Care and Use Committee of Wayne State
University.
4.1. Anti-calponin antibodies
The following previously described antibodies were used in the
present study: A rabbit polyclonal anti-h2-calponin antibody RAH2
that was raised by immunization with puriﬁed mouse h2-calponin
[28]; a mouse anti-h1-calponin mAb CP1 that was developed by
immunization with chicken gizzard calponin [29]; mouse anti-
h2-calponin mAbs CP21 [22] and 1D2 [16] that were raised by
immunizations with mouse and human h2-calponin, respectively.
4.2. Immunohistochemistry
To examine the expression and distribution of h1- and h2-cal-
ponins in human prostate tissue, thin parafﬁn sections were
stained with anti-h2-calponin mAb 1D2 followed by horseradish
peroxidase-labeled anti-mouse IgG second antibody (Sigma) and
H2O2-daminobenzidin substrate reactions using standard immu-
nohistochemical method [16,17]. Hybridoma cultural supernatant
was used to avoid potential autoantibody reactivity in adult animal
sera or mouse ascites ﬂuid to cytokeratins (unpublished observa-
tions). SP2/0 myeloma cultural supernatant was used as control.
Counterstaining with 0.6% hematoxylin for 20 s was used to out-
line the tissue morphology for comparison with H&E stained sec-
tions. The results were examined using a Zeiss Axiovert 100H
microscope and photographed.
4.3. SDS–polyacrylamide gel electrophoresis (PAGE) and Western
blotting
Total protein was extracted from discarded anonymous human
prostate tissue samples removed during surgery by homogeniza-
tion in SDS–PAGE sample buffer containing 2% SDS (to rapidly inac-
tivate endogenous proteases) using a high-speed mechanical tissue
homogenizer. Total protein extracts from cultured cells were pre-
pared by direct lysis of monolayer cells in SDS–PAGE sample buffer
after washing with phosphate buffered saline (PBS).
The protein extracts were heated at 80 C for 5 min, clariﬁed by
centrifugation at top speed in a microcentrifuge, and examined
using SDS–PAGE with 12% gel in Laemmili buffers and acrylam-
ide:bisacrylamide ratio of 29:1. Contents and integrity of the pro-
tein samples were evaluated by staining the gels with Coomassie
Blue R250. Duplicate gels were electrically transferred to nitrocel-
lulose membranes for Western blotting using anti-calponin
antibodies and alkaline phosphatase-labeled anti-rabbit IgG or
anti-mouse IgG second antibody (Sigma), followed by 5-bromo-
4-chloro-3-indolyl phosphate/nitroblue tetrazolium chromogenic
substrate reaction [16].4.4. Cell cultures
Human prostate cancer cell lines PC3 and its metastatic deriva-
tive PC3-M [27] were cultured in RPMI-1640 containing 10% fetal
bovine serum (FBS), 2 mM L-glutamine, 100 i.u./mL penicillin and
50 i.u./mL streptomycin at 37 C in 5% CO2.
Two pairs of non-malignant versus malignant/cancerous pri-
mary human prostate epithelial cell lines 1542NPTX (non-malig-
nant)/1542CP3TX (malignant) and 1532NPTX (non-malignant)/
1532CPTX (malignant) [30] were cultured in keratinocyte media
(Invitrogen) containing 5% FBS, 10 mM HEPES, 2 mM L-glutamine,
100 i.u./mL penicillin and 50 i.u./mL streptomycin at 37 C in 5%
CO2.
Primary ﬁbroblasts were isolated as described previously [31]
from leg muscles of adult wild type and h2-calponin knockout
mice [21]. Brieﬂy, muscles were isolated under sterile conditions
immediately after euthanasia and minced with a pair of sharp scis-
sors in DMEM containing 0.5% pancreatin and 0.125% trypsin. Trit-
urated with a 10 mL pipette, incubated at 37 C for 6 min,
triturated again and incubated for 7 more min, the digestion mix
was passed through a 100 lmmesh and the isolated cells were col-
lected by centrifugation at 200g for 5 min, re-suspended in
DMEM containing 20% FBS, 2 mM L-glutamine, 100 i.u./mL penicil-
lin and 50 i.u./mL streptomycin, and incubated in cultural dishes in
5% CO2 at 37 C for 1 h. The non-attached cells were discarded to
selectively culture the adherent ﬁbroblasts. Second and third pas-
sages of the primary ﬁbroblasts were used for experiments.
4.5. Immunoﬂuorescence microscopy
Pre-cleaned glass cover slips were coated with 0.1% gelatin and
dried under UV radiation before being placed in culture dish for the
seeding of PC3 and PC3-M cells. Coverslips with a monolayer of
PC3 and PC3-M cells were collected and washed with PBS. The cells
were ﬁxed with cold acetone for 30 min. After blocking with 1%
BSA in PBS in a humidity box at room temperature for 30 min,
the coverslips were incubated with anti-h2-calponin mAb 1D2 at
room temperature for 2 h. After washes with PBS containing
0.05% Tween-20, the coverslips were stained with ﬂuorescein iso-
thiocyanate (FITC)-conjugated goat anti-mouse IgG second anti-
body (Sigma) and tetramethylrhodamine isothiocyanate (TRITC)-
conjugated phalloidin (Sigma) (for F-actin) at room temperature
for 1 h. After ﬁnal washes with PBS containing 0.05% Tween-20,
the coverslips were mounted on glass slides and examined using
confocal microscopy for the cellular localization of h2-calponin
and the relationship to the actin cytoskeleton.
4.6. Transfective expression of h2-calponin
Transfection of PC3-M human prostate cancer cells with recom-
binant pcDNA3.1 plasmids encoding mouse h2-calponin [22] was
carried out with Lipofectamin (Invitrogen) following the manufac-
turer’s protocol. 2  106 of PC3-M cells were seeded in a 100 mm
culture dish that the transfection was carried out when the mono-
layer culture reached 60–80% conﬂuence. Twomicrogram of super-
coil recombinant plasmid DNA in 100 lL RPMI-1640 was mixed
with 5 lL of Lipofectamin in 100 lL RPMI-1640 and incubated at
room temperature for 20 min. The Lipofectamin-DNA complex
was then gently mixed with 5 mL of RPMI-1640 and added to the
culture dish to replace the cultural media. The cells were incubated
in 5% CO2 at 37 C for 6 h before adding 5 mL fresh RPMI-1640
media containing 20% FBS without antibiotics.
To establish stable transfection of PC3-M cells, the cell culture
was selected by 400 lg/mL of G418. G418-resistant colonies were
individually picked from the culture dish by trypsinization in small
cylinders greased to the dish. The cells were expanded and samples
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polymerase chain reaction. Overexpression of mouse h2-calponin
in PC3-M cells was examined on total cellular protein extracts
using Western blot as above.
4.7. Cell proliferation assay
To investigate the effects of h2-calponin on the rate of cell pro-
liferation, we employed the Crystal Violet method as described
previously [22]. Cells were seeded in 96-well culture plates at
2  103 cells per well in 200 lL of culture media. The cultures were
stopped at a series of time points by adding 20 lL per well of 11%
glutaraldehyde to ﬁx the cells. After gently shaking at room tem-
perature for 15 min, the plates were washed three times with dou-
ble distilled water and air-dried. The plates were then stained with
100 lL per well of 0.1% Crystal Violet (Sigma) in 20 mM 2-[N mor-
pholino]ethanesulfonic acid (MES) buffer (pH 6.0). After gentle
shaking at room temperature for 20 min, excess dye was removed
by extensive washing with double distilled water and the plates
were air-dried prior to extracting the bound dye with 100 lL per
well of 10% acetic acid. Optical density of the dye extracts was
measured at 595 nm using an automated microplate reader
(Benchmark, BioRad Labs).
4.8. Cell culture on polyacrylamide gel substrates of different stiffness
Thin layers of polyacrylamide gel were formed to provide cell
culture substrates of different stiffness [32,33]. Hard (5% acrylam-
ide and 0.3% bisacrylamide with elastic modulus = 8 kPa) and soft
(5% acrylamide and 0.03% bisacrylamide with elastic modu-
lus = 1 kPa) gels approximately 70 lm thick were prepared and
covalently coated with type I collagen as described previously
[16,34]. To examine the effect of cytoskeletal tension generated
from substrate stiffness on the expression of h2-calponin in pros-
tate cancer cells, PC3 and PC3-M cells were cultured on the hard
and soft gels as well as on plastic dish (as an extremely high stiff-
ness control) for 3 days, washed extensively with PBS, and harvest
by direct lysis in SDS-gel sample buffer. The level of h2-calponin
was examined using Western blot as above.
4.9. In vitro wound healing assay
To examine the role of h2-calponin in the motility of prostate
cancer cells, PC3 versus PC3-M, 1532NPTX versus 1532CPTX, and
1542NPTX versus 1542CP3TX cells, h2-calponin cDNA versus vec-
tor-only stable-transfected PC3-M cells, and primary ﬁbroblasts
from h2-calponin knockout versus wild type mice, were seeded
on 6-well culture plates at 2  105 cells per well and cultured for
3 days. As described previously [35], the conﬂuent monolayer cells
were scratch-wounded with a thin pipette tip. To monitor the heal-
ing process, phase-contrast images were photographed every 2 h
for the transfected PC3-M cells and every 1.5 h for the other cell
types. The width of the wound was measured and plotted against
time to determine the rate of cell migration.
4.10. Cell adhesion assay
Adhesion velocity of PC3 and PC3-M cells to uncoated or 0.2 lg/
mL collagen type I-coated plastic culture plates was measured at a
series of time points using Crystal Violet staining as above after
removing non-adhered cells with PBS washes.
Cell spreading area on plastic substrate was also measured to
evaluate the effect of h2-calponin on cell adhesion. PC3 and PC3-
M cells were seeded on uncoated 6-well culture plates and
phase-contrast images were taken after 8 h of culture. The cellspreading area was measured from the photographs using NIH
Image program version 1.61.
To investigate the effect of h2-calponin on the stability of actin
cytoskeleton in adherent cells, the round up velocity of PC3 versus
PC3-M cell was measured during trypsinization. 4  105 cells per
well were seeded in 6-well plates and cultured for 24 h, the mono-
layer cells were washed with PBS and treated with a low concen-
tration trypsin-EDTA solution (0.025% trypsin, 0.1 mM EDTA).
Phase-contrast images were taken 10 min after the treatment
and the round up cells were counted in randomly selected areas
against the remaining adhered cells to evaluate the round up
velocity.
To examine the role of h2-calponin in cell adhesion to sub-
strates of different stiffness, PC3, PC3-M, 1532NPTX, 1532CPTX,
1542NPTX and 1542CP3TX cells were seeded on hard (8 kPa) and
soft (1 kPa) polyacrylamide gels. Phase contrast images were taken
after 8 h of culture. The adhered cells were recognized by the pho-
tographic image and counted from multiple randomly selected
areas.
4.11. Data analysis
Densitometry analysis of SDS-gels, Western blots and confocal
microscopic images were performed using NIH Image program
version 1.61 on high resolution digital images. Western blots were
quantiﬁed by normalization to the amount of actin in parallel Coo-
massie Blue-stained gels. The quantitative data of Western blots,
cell proliferation, wound healing and cell adhesion assays are pre-
sented as mean ± SD. Statistical analysis was performed with
unpaired two-tail Student’s t-test using the Microsoft Excel com-
puter program.
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